753 related articles for article (PubMed ID: 30582449)
1. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
[TBL] [Abstract][Full Text] [Related]
2. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo.
Guo Y; VanDusen NJ; Zhang L; Gu W; Sethi I; Guatimosim S; Ma Q; Jardin BD; Ai Y; Zhang D; Chen B; Guo A; Yuan GC; Song LS; Pu WT
Circ Res; 2017 Jun; 120(12):1874-1888. PubMed ID: 28356340
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.
Ahmed BY; Chakravarthy S; Eggers R; Hermens WT; Zhang JY; Niclou SP; Levelt C; Sablitzky F; Anderson PN; Lieberman AR; Verhaagen J
BMC Neurosci; 2004 Jan; 5():4. PubMed ID: 15005815
[TBL] [Abstract][Full Text] [Related]
5. Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca
Reynolds JO; Quick AP; Wang Q; Beavers DL; Philippen LE; Showell J; Barreto-Torres G; Thuerauf DJ; Doroudgar S; Glembotski CC; Wehrens XH
Int J Cardiol; 2016 Dec; 225():371-380. PubMed ID: 27760414
[TBL] [Abstract][Full Text] [Related]
6. Targeting transgene to the heart and liver with AAV9 by different promoters.
Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
[TBL] [Abstract][Full Text] [Related]
7. Design and Production of Heart Chamber-Specific AAV9 Vectors.
Bilal AS; Thuerauf DJ; Blackwood EA; Glembotski CC
Methods Mol Biol; 2022; 2573():89-113. PubMed ID: 36040589
[TBL] [Abstract][Full Text] [Related]
8. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver.
Piras BA; O'Connor DM; French BA
PLoS One; 2013; 8(9):e75894. PubMed ID: 24086659
[TBL] [Abstract][Full Text] [Related]
10. AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.
Schwab DM; Tilemann L; Bauer R; Heckmann M; Jungmann A; Wagner M; Burgis J; Vettel C; Katus HA; El-Armouche A; Müller OJ
Gene Ther; 2018 Jan; 25(1):13-19. PubMed ID: 29350681
[TBL] [Abstract][Full Text] [Related]
11. A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity.
Chamberlain K; Riyad JM; Garnett T; Kohlbrenner E; Mookerjee A; Elmastour F; Benard L; Chen J; VandenDriessche T; Chuah MK; Marian AJ; Hajjar RJ; Gurha P; Weber T
Hum Gene Ther; 2018 Aug; 29(8):927-937. PubMed ID: 29641321
[TBL] [Abstract][Full Text] [Related]
12. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
[TBL] [Abstract][Full Text] [Related]
13. Enhancing atrial-specific gene expression using a calsequestrin cis-regulatory module 4 with a sarcolipin promoter.
Yoo J; Kohlbrenner E; Kim O; Hajjar RJ; Jeong D
J Gene Med; 2018 Dec; 20(12):e3060. PubMed ID: 30393908
[TBL] [Abstract][Full Text] [Related]
14. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
Prasad KM; Smith RS; Xu Y; French BA
J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing.
Ma Y; Yu L; Pan S; Gao S; Chen W; Zhang X; Dong W; Li J; Zhou R; Huang L; Han Y; Bai L; Zhang L; Zhang L
FEBS J; 2017 Oct; 284(19):3262-3277. PubMed ID: 28763160
[TBL] [Abstract][Full Text] [Related]
16. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.
Prasad KM; Xu Y; Yang Z; Acton ST; French BA
Gene Ther; 2011 Jan; 18(1):43-52. PubMed ID: 20703310
[TBL] [Abstract][Full Text] [Related]
17. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
[TBL] [Abstract][Full Text] [Related]
18. AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models.
Zhong P; Peng J; Liu T; Ding HS
Cardiovasc Toxicol; 2022 Jan; 22(1):88-96. PubMed ID: 34674150
[TBL] [Abstract][Full Text] [Related]
19. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
[TBL] [Abstract][Full Text] [Related]
20. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.
Du L; Kido M; Lee DV; Rabinowitz JE; Samulski RJ; Jamieson SW; Weitzman MD; Thistlethwaite PA
Mol Ther; 2004 Sep; 10(3):604-8. PubMed ID: 15336660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
